[Ovid] Brigatinib combined with cetuximab in the fifth-line treatment of non-small cell lung cancer with EGFR p.C797S mutation in critically ill patients: a report of two cases and literature review

 Close Closed
5931835343 Post time 2024-4-27 00:15:53 | Show all posts |Read mode
Reward20points

journal:Anti-Cancer Drugs

Authors:Juanjuan Liu; Hongtao Lei; Ding Zhang; Ning Zhang

Published date:--

DOI:10.1097/cad.0000000000001598

PDF link:https://journals.lww.com/10.1097/CAD.0000000000001598

Article link:http://dx.doi.org/10.1097/cad.0000000000001598

Article Source:Ovid Technologies (Wolters Kluwer Health)

Remark:
Reply

Use magic Donate Report

All Reply1 Show all posts
5931835343 Post time 2024-4-27 08:32:42 | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
Reply

Use magic Donate Report


Senior Member
  • post

  • reply

  • points

    1900

Latest Reply



Return to the list